Tergene Biotech Limited - Company Profile

Q: Who are the current directors of Tergene Biotech Limited?

The current directors of Tergene Biotech Limited are Umesh Krishnamoorthy, Mosuvan Kuppusamy, Sivakumaran Meenakshisunderam, Vijayudu Gajulapalli, Kuppusamy Sathyan, Santhanam Subramanian, Lonkari Sudhakar.

It is a life sciences public limited company based in Hyderabad, Telangana, India, established in 2008.

2008 Hyderabad, Telangana, India Active

Last Updated: December 24, 2025

Access Report

About Tergene Biotech Limited

Tergene Biotech Limited, a active public limited company, was established on 07 March 2008 in Hyderabad, Telangana, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: U24230TG2008PLC113178. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹47.50 Cr and a paid-up capital of ₹47.15 Cr.

Formerly known as Tergene Biotech Private Limited. It upholds a compliant status. Its leadership includes Umesh Krishnamoorthy (Director), Mosuvan Kuppusamy (Director), Sivakumaran Meenakshisunderam (Director). Past directors included Umesh Krishnamoorthy, Mosuvan Kuppusamy, Sivakumaran Meenakshisunderam. It holds no open charges and ₹1.18 Cr settled loans. Its latest AGM occurred on 22 September 2025, with the balance sheet filed on 31 March 2025. It is based at Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1 Hyderabad Knowledge City, Raidurg Panmak, Tha, Hyderabad, Telangana, 500032.

Company Details

CIN/LLPIN
U24230TG2008PLC113178
Registration Number
113178
Incorporation Date
07 March 2008
Authorized Capital
₹47.50 Cr
Paid-Up Capital
₹47.15 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 47.50 Cr as on 24-12-2025
Paid Up Capital ₹ 47.15 Cr as on 24-12-2025
Company Age 17 Year, 11 Months
Last Filing with ROC 31 Mar 2025
Satisfied Charges ₹ 1.18 Cr as on 24-12-2025
Revenue Growth **** 107.03% (FY 2023)
Profit Growth **** 20.31% (FY 2023)
Ebitda **** -43.79% (FY 2023)
Net Worth -20.43% (FY 2023)
Total Assets -27.80% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Tergene Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Tergene Biotech Limited?

Current Directors

Name	Designation	Appointment Date	Status
Umesh Krishnamoorthy	Director	28 Jun 2023	Current
Mosuvan Kuppusamy	Director	07 Mar 2008	Current
Sivakumaran Meenakshisunderam	Director	01 Apr 2015	Current
Kuppusamy Sathyan	Director	07 Mar 2008	Current
Santhanam Subramanian	Director	26 Aug 2016	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	20 Aug 2023	Past
Pramod Abcsdd	Director	01 Apr 2015	Past
Pramod Abcsdd	Additional Director	30 Sep 2015	Past
Pramod Abcsdd	Cfo(Kmp)	-	Past
Pramod Abcsdd	Director	01 Apr 2015	Past
Pramod Abcsdd	Additional Director	25 Jul 2022	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Tergene Biotech.

Tergene Biotech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 107.03% increase. The company also saw a substantial improvement in profitability, with a 20.31% increase in profit. The company's net worth observed a substantial decline by a decrease of 20.43%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

107.03%

*******

Revenue from Operations

*******

-100.00%

*******

Total Assets

*******

-27.80%

*******

Profit or Loss

*******

20.31%

*******

Net Worth

*******

-20.43%

*******

EBITDA

*******

-43.79%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Tergene Biotech?

In 2023, Tergene Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹11,803,000.00

Charges Breakdown by Lending Institutions

Biotechnology Industry Research Assistance Council : 1.18 Cr

Latest Charge Details

Date	Lender	Amount	Status
30 Aug 2012	Biotechnology Industry Research Assistance Council	₹1.18 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Tergene Biotech?

Unlock and access historical data on people associated with Tergene Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Tergene Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tergene Biotech's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Tergene Biotech

Recent Activity within the Organization

Annual General Meeting

Progress on Tergene Biotech Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records. was documented.
22 Sep 2025
Balance Sheet

Progress on Tergene Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
31 Mar 2025
Director Appointment

Vijayudu Gajulapalli was appointed as a Company Secretary was appointed as a Company Secretary on 12 Jun 2024 & has been associated with this company since 1 year 8 months . was recorded as a recent event.
12 Jun 2024
Director Appointment

Progress on Umesh Krishnamoorthy was appointed as a Director was appointed as a Director on 28 Jun 2023 & has been associated with this company since 2 years 7 months . was documented.
28 Jun 2023
Director Appointment

Lonkari Sudhakar was appointed as a CFO was appointed as a CFO on 21 Mar 2022 & has been associated with this company since 3 years 10 months . was recorded as a recent event.
21 Mar 2022
Charges

The activity A charge registered on 30 Aug 2012 via Charge ID 10373010 with Biotechnology Industry Research Assistance Council was fully satisfied on 15 Nov 2021. was completed.
15 Nov 2021

Explore recent activity and updates - View Recent Activity